Certain A Shares of Zhejiang Tailin BioEngineering Co.,Ltd are subject to a Lock-Up Agreement Ending on 15-JAN-2023.
January 15, 2023
Share
Certain A Shares of Zhejiang Tailin BioEngineering Co.,Ltd are subject to a Lock-Up Agreement Ending on 15-JAN-2023. These A Shares will be under lockup for 1098 days starting from 13-JAN-2020 to 15-JAN-2023.
Details:
The company's actual controller Ye Dalin, Ni Weiju and Ningbo Gaode Equity Investment Management Partnership Enterprise (Limited Partnership) and Tianfeng Securities Co., Ltd., BOC International (China) Limited, Li Kaixian, Guo Jinjiang promised that within 36 months after the listing date, will not transfer nor entrust to others for management shares in the company, nor allow the company to repurchase the said shares.
The company's other remaining 10 shareholders promised that within 12 months after the listing date, will not transfer nor entrust to others for management shares in the company, nor allow the company to repurchase the said shares.
Zhejiang Tailin Bioengineering Co., Ltd. is a China-based company mainly engaged in pharmaceutical equipment business. The Company's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The Company distributes its products within domestic market and to overseas markets.
ZHEJIANG TAILIN BIOENGINEERING CO.,LTD 